Helena Idborg

1.8k total citations
57 papers, 1.3k citations indexed

About

Helena Idborg is a scholar working on Rheumatology, Molecular Biology and Pharmacology. According to data from OpenAlex, Helena Idborg has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 20 papers in Molecular Biology and 20 papers in Pharmacology. Recurrent topics in Helena Idborg's work include Inflammatory mediators and NSAID effects (20 papers), Systemic Lupus Erythematosus Research (17 papers) and Eicosanoids and Hypertension Pharmacology (9 papers). Helena Idborg is often cited by papers focused on Inflammatory mediators and NSAID effects (20 papers), Systemic Lupus Erythematosus Research (17 papers) and Eicosanoids and Hypertension Pharmacology (9 papers). Helena Idborg collaborates with scholars based in Sweden, Germany and United States. Helena Idborg's co-authors include Per‐Olof Edlund, Per‐Johan Jakobsson, Sven P. Jacobsson, Ina Schuppe‐Koistinen, Marina Korotkova, Stig Jacobsson, Leila Zamani, Olav M. Kvalheim, Vilija Oke and Elisabet Svenungsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Analytical Chemistry.

In The Last Decade

Helena Idborg

57 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helena Idborg Sweden 21 645 272 257 188 185 57 1.3k
Xiaotao Duan China 22 1.1k 1.7× 329 1.2× 347 1.4× 16 0.1× 102 0.6× 47 1.7k
Elaine McKilligin United Kingdom 6 1.2k 1.9× 156 0.6× 253 1.0× 54 0.3× 24 0.1× 8 1.9k
Herminia González‐Navarro Spain 25 649 1.0× 61 0.2× 344 1.3× 41 0.2× 78 0.4× 59 1.8k
Ylva Magnusson Sweden 17 669 1.0× 91 0.3× 133 0.5× 48 0.3× 40 0.2× 28 1.6k
David Friedecký Czechia 21 632 1.0× 144 0.5× 42 0.2× 128 0.7× 25 0.1× 113 1.3k
Míriam Guillén Navarro Spain 18 922 1.4× 243 0.9× 90 0.4× 24 0.1× 60 0.3× 34 1.6k
Cexiong Fu United States 14 1.3k 2.1× 234 0.9× 263 1.0× 38 0.2× 25 0.1× 21 2.0k
Susan E. Barrow United Kingdom 23 287 0.4× 133 0.5× 308 1.2× 80 0.4× 396 2.1× 47 1.6k
Xiaojing Huang China 24 1.2k 1.8× 111 0.4× 182 0.7× 25 0.1× 76 0.4× 50 2.1k
Christopher Savard United States 22 906 1.4× 54 0.2× 263 1.0× 22 0.1× 61 0.3× 43 2.5k

Countries citing papers authored by Helena Idborg

Since Specialization
Citations

This map shows the geographic impact of Helena Idborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Idborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Idborg more than expected).

Fields of papers citing papers by Helena Idborg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Idborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Idborg. The network helps show where Helena Idborg may publish in the future.

Co-authorship network of co-authors of Helena Idborg

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Idborg. A scholar is included among the top collaborators of Helena Idborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Idborg. Helena Idborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hambardzumyan, Karen, Carl Hamsten, L. Lourido, et al.. (2025). Association of matrix metalloproteinase 7 and the alpha-chain of fibrinogen at baseline with response to methotrexate at 3 months in patients with early rheumatoid arthritis. BMC Rheumatology. 9(1). 56–56. 1 indexed citations
3.
Liu, Jianyang, Helena Idborg, Marina Korotkova, et al.. (2024). Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis. Arthritis Research & Therapy. 26(1). 61–61. 1 indexed citations
4.
Idborg, Helena, Liyuan Zhu, Huihui Li, et al.. (2023). Microsomal prostaglandin E synthase‐1 inhibition prevents adverse cardiac remodelling after myocardial infarction in mice. British Journal of Pharmacology. 180(15). 1981–1998. 6 indexed citations
5.
Liu, Jianyang, et al.. (2023). Microsomal prostaglandin E synthase-1 inhibition promotes shunting in arachidonic acid metabolism during inflammatory responses in vitro. Prostaglandins & Other Lipid Mediators. 167. 106738–106738. 7 indexed citations
6.
Idborg, Helena, Arash Zandian, Bo Nilsson, et al.. (2019). Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives. Arthritis Research & Therapy. 21(1). 62–62. 17 indexed citations
7.
Idborg, Helena. (2019). Symptom-based stratification of autoimmune diseases. The Lancet Rheumatology. 1(2). e76–e77. 3 indexed citations
8.
Lengqvist, Johan, Elena Ossipova, Helena Idborg, et al.. (2019). Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients—immune-related candidate proteins affected by TNF blocking treatment. Arthritis Research & Therapy. 21(1). 60–60. 14 indexed citations
9.
Pawelzik, Sven‐Christian, A. Avignon, Helena Idborg, et al.. (2019). Urinary prostaglandin D2 and E2 metabolites associate with abdominal obesity, glucose metabolism, and triglycerides in obese subjects. Prostaglandins & Other Lipid Mediators. 145. 106361–106361. 19 indexed citations
10.
Idborg, Helena, Arash Zandian, Ann‐Sofie Sandberg, et al.. (2018). Systemic lupus erythematosus subgroups, with features of antiphospholipid or Sjogren's syndrome, differ in molecular signatures and treatment perspectives. Scandinavian Journal of Rheumatology. 47. 2–2. 2 indexed citations
11.
Surowiec, Izabella, Erik Johansson, Helena Idborg, et al.. (2017). Multivariate strategy for the sample selection and integration of multi-batch data in metabolomics. Metabolomics. 13(10). 114–114. 16 indexed citations
12.
Lukić, Ana, Jie Ji, Helena Idborg, et al.. (2016). Pulmonary epithelial cancer cells and their exosomes metabolize myeloid cell-derived leukotriene C4 to leukotriene D4. Journal of Lipid Research. 57(9). 1659–1669. 42 indexed citations
13.
Raouf, Joan, Helena Idborg, Filip Bergqvist, et al.. (2016). Arg126 and Asp49 Are Essential for the Catalytic Function of Microsomal Prostaglandin E2 Synthase 1 and Ser127 Is Not. PLoS ONE. 11(9). e0163600–e0163600. 6 indexed citations
14.
Leclerc, P., Heidi Wähämaa, Helena Idborg, et al.. (2013). IL‐1β/HMGB1 Complexes Promote The PGE2 Biosynthesis Pathway in Synovial Fibroblasts. Scandinavian Journal of Immunology. 77(5). 350–360. 41 indexed citations
15.
Idborg, Helena, Charlotte Larsson, Natalia Nekhotiaeva, et al.. (2013). Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation. Prostaglandins & Other Lipid Mediators. 107. 26–34. 60 indexed citations
16.
Rasmuson, Agnes, Helena Idborg, Lova Segerström, et al.. (2013). Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma. Carcinogenesis. 34(5). 1081–1088. 62 indexed citations
17.
Idborg, Helena, et al.. (2013). Effects of mPGES-1 deletion on eicosanoid and fatty acid profiles in mice. Prostaglandins & Other Lipid Mediators. 107. 18–25. 30 indexed citations
18.
Gheorghe, Karina, Helena Idborg, Ivonne Wobst, et al.. (2012). Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue. Arthritis Research & Therapy. 14(3). R121–R121. 12 indexed citations
19.
Idborg, Helena, Leila Zamani, Per‐Olof Edlund, Ina Schuppe‐Koistinen, & Stig Jacobsson. (2005). Metabolic fingerprinting of rat urine by LC/MSPart 1. Analysis by hydrophilic interaction liquid chromatography–electrospray ionization mass spectrometry. Journal of Chromatography B. 828(1-2). 9–13. 120 indexed citations
20.
Idborg, Helena, Leila Zamani, Per‐Olof Edlund, Ina Schuppe‐Koistinen, & Stig Jacobsson. (2005). Metabolic fingerprinting of rat urine by LC/MSPart 2. Data pretreatment methods for handling of complex data. Journal of Chromatography B. 828(1-2). 14–20. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026